New entrant redefines product and service offering in pharmaceutical packaging sector
Hamburg, Germany – March 30th, 2021
LINDAL Group creates a new and stand-alone provider of spray packaging solutions for pharmaceutical applications. The new company RxPack is established together with Coster Group. RxPack will unlock value for its customers with a distinctive product offering and tap the growth opportunities in the regulated and non-regulated pharmaceutical sectors.
The new company RxPack (pronounced R-x-Pack) will include the highly complementary product lines from LINDAL and Coster for spray packaging solutions for pharmaceutical applications. RxPack will be among the only suppliers that offer both pulmonary inhalation devices such as aerosol MDIs and nasal pumps as well as other aerosol and dispensing solutions for the regulated and non-regulated pharmaceutical sectors. These technologies provide the most efficient and cost-effective way to treat respiratory diseases via inhaled drug delivery. RxPack’s packaging solutions offering will be supplemented with the corresponding aerosol filling machinery for the pharmaceutical sector, forming a distinctive and highly competitive product portfolio. RxPack will thus provide even better responses to its customers’ needs.
RxPack will operate from the current facility of LINDAL’s pharmaceutical business in Oggiono, north of Milan in Italy. It is expected to enter business by the end of this year, after the approval from the relevant authorities. LINDAL and Coster will each have an equal share in RxPack.
“RxPack is being established to take our pharmaceutical business to the next level and to create momentum in the pharmaceutical packaging sector”, says Katharina Lilienthal, Chairwoman of the Board of LINDAL and representative of the LINDAL shareholder family. “With its distinctive product portfolio and its strong financial resources, RxPack is ideally positioned to grow in the non-regulated sector and to enter the highly attractive regulated sector.”
RxPack starts from a position of strength
RxPack will start with a strong operational base. With the Oggiono site, it will be able to use the existing production facility already focused on the pharmaceutical business. The site offers excellent working and production conditions including the required cleanrooms and laboratories and the opportunity to build further capabilities to serve the pharmaceutical sector. RxPack will start its operations with approximately 60 employees, most of whom are transferring from LINDAL and all of whom have previously worked in the pharmaceutical business. Furthermore, RxPack will hire additional industry experts to further strengthen the organization.
An initial investment of four million EUR has been allocated for upgrading and extending clean room manufacturing capabilities. Thereafter, further investments are planned to drive innovation and growth.
RxPack will operate completely independently
Outside of RxPack, LINDAL and Coster are competitors in numerous areas and will remain so. RxPack will therefore operate as a stand-alone entity that is completely independent from the two groups.
RxPack will solely focus on the pharmaceutical sector, a segment requiring specialist expertise and manufacturing technology, and thus on the production and distribution of products used exclusively in this sector. LINDAL, just like Coster, will continue to focus on its core business, serving customers in the personal care, home care, technical and industrial sectors. However, the BOV products manufactured by LINDAL and Coster will not be included in RxPack, as they are based on a different technology which is deployed in applications not only for the pharmaceutical industry, but also for many other sectors. LINDAL and Coster will both continue to offer BOV products, also for the pharmaceutical sector, and remain strong competitors in this area.
To ensure its independence, RxPack will have a fully autonomous organization with corresponding governance and separate facilities. The facility in Oggiono will be exclusively dedicated to RxPack. All other non-pharmaceutical activities at this location will therefore be relocated to other LINDAL facilities during a carefully managed transition period and traded by LINDAL in Italy via a new LINDAL site nearby Oggiono.
For more information, please contact: firstname.lastname@example.org
About LINDAL Group
LINDAL Group is a worldwide leader in the design, manufacture and sale of valves, actuators and spray caps used in aerosol products. The Hamburg, Germany-based company has more than 60 years of experience with innovative dispensing solutions for the cosmetics, household, pharmaceuticals, food and technical industries.
The LINDAL Group is represented by subsidiaries and licensees in more than 15 countries throughout Europe, Asia and The Americas. The company is renowned for its innovative designs, which deliver optimal functionality and return on investment. As a result, LINDAL packaging solutions are the choice of the world’s most prestigious and trusted brands.